- Wall Street financial institutions have updated their ratings and price targets for several prominent companies.
- Needham raised Everpure's target to $185, while HSBC downgraded Constellation Brands and cut its target to $135.
- Cantor Fitzgerald boosted Eli Lilly's target to $1,440 and Amgen's target to $440 amid multiple analyst adjustments.